Pharma News

Phase 3 Data on Samsung Bioepis’ Eculizumab Biosimilar Confirms Equivalence to Soliris

www.biosimilarsrr.com, June 14th, 2022

Celltrion Pharm to sell Takeda’s diabetes treatment exclusively from July

www.koreabiomed.com, June 9th, 2022

Cambrex Acquires Q1 Scientific

www.pharmaceuticalcommerce.com, June 2nd, 2022

DFE Pharma Introduces India Center of Excellence

www.pharmaceuticalcommerce.com, May 26th, 2022

Catalent Invests $175 Million to Expand Manufacturing at Winchester, Kentucky

www.coldchainplatform.com, May 19th, 2022

Bora Pharmaceuticals continues to expand into the global CDMO market with the acquisition of Eden Biologics

www.coldchainplatform.com, May 13th, 2022

LOTTE to Purchase East Syracuse, New York BMS Manufacturing Facility

www.coldchainplatform.com, May 13th, 2022

Cytiva opening new facility in Switzerland

www.cytivalifesciences.com, May 10th, 2022

Kite Receives Approval of State-of-the-art Car T-Cell Therapy Manufacturing Facility

www.coldchainplatform.com, April 19th, 2022

Catalent Acquires UK Biologics Facility

www.pharmaceuticalcommerce.com, April 7th, 2022

Follow CCP

Read More